Total Funding
13
Total FundingSeries B raised
Growth Score
pts
Heat Score
-4 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
285268
Panacela Labs is a clinical-stage biotechnology company focusing on oncology and orphan drug development.
Andrey Gudkov: Chairman of Scientific Board- Dmitry Tyomkin: MD, Chief Medical Officer
About the Company
Panacela Labs, Inc. is a joint venture company founded in 2011 by Cleveland BioLabs (Nasdaq:CBLI), a clinical-stage biotechnology company with a focus on oncology and orphan drug development, and Open Joint Stock Company “RUSNANO”, the largest Russian investment company, in collaboration with Roswell Park Cancer Institute, Children’s Cancer
Institute of Australia and Cleveland Clinic Foundation. Panacela Labs is 54.6% owned by Cleveland BioLabs. Panacela Labs has residency in the Innovation Center "Skolkovo".
